# AbbVie Inc.: Form 8-K, filed Feb 2, 2024

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2024-02-02
- Accepted by EDGAR: Feb 2, 2024, 07:51 ET
- Period: 2024-02-02
- Accession: 0001551152-24-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/abbv-20240202.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000155115224000007/abbv-20240202.htm

Filed Feb 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001551152-24-000007. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
